Space Capsule With Cannabis Seeds, Ashes Of 166 People Crashes Into The Ocean
In a tragic turn of events, German aerospace startup The Exploration Company (TEC) has announced the failure of its ambitious Mission Possible. Launched on June 23, the mission aimed to return safely after orbiting the Earth twice with the ashes of 166 people and some hemp seeds. However, the capsule, named Nyx, sank into the Pacific Ocean upon its return to Earth.
The mission was designed by Texas-based space burial company Celestis, who envisioned not just sending the ashes into space but bringing them back to Earth as a symbolic gesture. After launch, the capsule successfully reached Earth's orbit and completed two orbits, with all onboard instruments functioning properly. However, contact was lost just minutes before its scheduled re-entry into Earth's atmosphere. It was expected to land safely in the Pacific Ocean, but TEC later confirmed that the capsule had crashed directly into the ocean. No parts or ashes could be recovered.
In addition to the human ashes, the capsule contained marijuana seeds as part of the Martian Grow Project, a citizen science mission to explore the feasibility of growing marijuana on Mars. Unfortunately, these seeds are now buried deep in the ocean.
Celestis co-founder Charles M. Chafer expressed deep sorrow over the incident, acknowledging the grief of the families involved in the mission. He praised their courage and highlighted the historical significance of their participation. Despite the mission's failure, he said the fact that the ashes of 166 people orbited the Earth remains a respectable achievement.
TEC has also recognised the technical shortcomings of the mission but emphasised the valuable lessons learned. The company has committed to launching similar missions in the future, aiming to achieve safe 'return space burials' and chart a new direction in the coming times.
Get breaking news, in-depth analysis, and expert perspectives on everything from geopolitics to diplomacy and global trends. Stay informed with the latest world news only on News18. Download the News18 App to stay updated!
First Published:
July 07, 2025, 12:10 IST
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
4 hours ago
- NDTV
UGC Fellowship, PhD Exam June 2025 Rescheduled, Check Details Here
CSIR UGC NET June 2025: The National Testing Agency (NTA) has revised the schedule for the Joint CSIR-UGC NET June 2025 exam. In response to multiple representations from candidates citing a clash with the Haryana Teacher Eligibility Test (HTET) 2024, which is scheduled on the same dates, the CSIR UGC NET exam will now be conducted on a single day on July 28. The CSIR UGC NET is a national-level Computer Based Test (CBT) that determines eligibility for the award of Junior Research Fellowship (JRF), appointment as Assistant Professor, and admission to PhD programmes in Indian colleges and universities. As per the revised schedule, the exam on July 28 will cover all five subjects: Mathematical Sciences Earth, Atmospheric, Ocean and Planetary Sciences Chemical Sciences Life Sciences Physical Sciences Candidates will receive their exam city details 8 to 10 days before the examination through an advance city intimation slip. For updates and further details, candidates are advised to regularly check the official NTA websites: and Queries can be addressed to NTA via email at csirnet@ or through the helpline numbers 011-40759000 and 011-69227700.
Time of India
9 hours ago
- Time of India
Anthem Biosciences IPO: Rs 3,395 crore IPO to open on July 14
The initial public offering (IPO) of Anthem Biosciences will open for subscription on Monday, July 14. The Bengaluru-based CRDMO player is planning to raise Rs 3,395 crore through the issue. The issue will conclude on Wednesday, July 16. About Anthem Biosciences IPO The IPO is an Offer for Sale (OFS) and comprises stake sale aggregating up to Rs 350 crores each by Ganesh Sambasivam and K Ravindra Chandrappa who are promoter selling shareholders. Up to Rs 1,325 crores will be offloaded by Viridity Tone LLP and up to Rs 320 crores by Portsmouth Technologies LLC (Investor Selling Shareholders). by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Free P2,000 GCash eGift UnionBank Credit Card Apply Now Undo It also includes stake sales of Rs 320 crores each by Malay J Barua, Rupesh N Kinekar and Satish Sharma, up to Rs 80 crore by Prakash Kariabettan and up to Rs 10 crore by K Ramakrishnan. About Anthem Biosciences Anthem's business comprises Contract Research, Development and Manufacturing Organization (CRDMO) services and the manufacture and sale of specialty ingredients. It offers a comprehensive, integrated and highly customizable range of CRDMO services across the New Chemical Entity (NCE) and New Biological Entity (NBE) lifecycles. The company claims to have a strong presence across various modalities, such as RNAi, ADC, peptides, lipids and oligonucleotides, and manufacturing techniques, such as flow chemistry, enzymatic processes, biocatalysis and fermentation, offering a broad range of technology capabilities for drug development. It also manufactures and sells complex specialized fermentation-based Active Pharmaceutical Ingredients (APIs), including probiotics, enzymes, peptides, nutritional actives, vitamin analogues and biosimilars. Live Events Ajay Bhardwaj (Chairman, MD & CEO), Ganesh Sambasivam (Whole-time Director and Chief Scientific Officer), K Ravindra Chandrappa (Whole-time Director and Chief Operating Officer) and Ishaan Bhardwaj (Vice President) are the Promoters of the company. The company, which was incorporated in 2006, has two operational manufacturing facilities in India, Unit I (Bommassandra) and Unit II (Harohalli), both in Karnataka, with an aggregate annual custom synthesis capacity of 270 kL and fermentation capacity of 142 kL, as of March 31, 2025. According to the RHP, the company is in the process of expanding its custom synthesis capacity at Unit II (Harohalli) by 130 kL as well as expanding its custom synthesis capacity by 25kL and fermentation capacity by 40kL by constructing Unit III (Neoanthem Lifesciences Private Limited, wholly-owned Subsidiary), both expected to be fully operational by the first half of Fiscal 2026. Post-expansion activities, the aggregate annual custom synthesis capacity and fermentation capacity is expected to increase to 425 kL and 182 kL, respectively. The fermentation capacity of 182 kL is expected to be more than six times the capacity of the second largest player in this industry, according to the F&S Report. Anthem Biosciences financials Its revenue from operations increased by 30% to Rs 1,844 crores in FY25 from Rs 1,419 crores in FY24. The PAT for the year ended March 31, 2025 was Rs 451 crores, a jump of 22.86% over FY24. Sai Life Sciences Limited, Syngene International Limited , Cohance Lifesciences Limited , (Formerly Suven Pharmaceuticals) and Divi's Laboratories Limited are the listed peers of Anthem Biosciences, as per its RHP. Anthem Biosciences lead managers The Book Running Lead Managers to the offer are JM Financial Limited , Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited and Nomura Financial Advisory and Securities (India) Private Limited. The equity shares are proposed to be listed on BSE and NSE.
&w=3840&q=100)
Business Standard
11 hours ago
- Business Standard
Suhora, OSK partner to put India on hyperspectral map, tackle key issues
Suhora Technologies has teamed up with Orbital Sidekick to introduce high-resolution hyperspectral satellite services in India, enabling the identification of rare earth minerals, methane leaks, etc Shine Jacob Chennai Listen to This Article Suhora Technologies, a leading India-based space data analytics company, on Tuesday announced a strategic partnership with US-based Orbital Sidekick (OSK) to introduce first-of-its-kind high-resolution hyperspectral satellite services in India. Through this, India will be able to identify rare earth mineral reserves, detect methane leaks from space, and monitor various other geological developments. This landmark agreement makes Suhora the first Indian company to offer commercial operational hyperspectral data of wide-spectrum (VNIR-SWIR), marking a significant leap forward for the nation's earth observation and geospatial data analytics capabilities. Through this partnership, Suhora will integrate OSK's advanced hyperspectral imagery into its flagship SPADE platform.
